| Literature DB >> 34782536 |
Yuanni Huang1, Mian Bao1, Caixia Liu1, Shukai Zheng1, Taifeng Du1, Kusheng Wu1.
Abstract
Background & objectives: This study was to survey the apolipoprotein E (APOE) gene polymorphism distribution among Chinese Uyghur children and to explore the relationship between APOE gene polymorphism and the occurrence of urolithiasis.Entities:
Keywords: Apolipoprotein E; Uyghur children; gene polymorphism; urolithiasis
Mesh:
Substances:
Year: 2021 PMID: 34782536 PMCID: PMC8715683 DOI: 10.4103/ijmr.IJMR_1208_18
Source DB: PubMed Journal: Indian J Med Res ISSN: 0971-5916 Impact factor: 2.375
Apolipoprotein E (APOE) genotype distribution based on two single-nucleotide polymorphisms (rs429358 and rs7412)
| rs429358 | rs7412 |
|
|---|---|---|
| C/C | C/C | E4/4 |
| T/C | C/C | E3/4 |
| T/T | C/C | E3/3 |
| T/T | T/C | E2/3 |
| T/C | T/C | E2/4 |
| T/T | T/T | E2/2 |
Comparison of demographic characteristics and mineral profiles between the case and control groups (SD)
| Parameters | Case group (n=144) | Control group (n=274) |
|
|---|---|---|---|
| Age (yr) | 4.48±3.19 | 4.55±3.57 | 0.661 |
| Gender, n (%) | |||
| Male | 109 (75.7) | 175 (63.9) | 0.014 |
| Female | 35 (24.3) | 99 (36.1) | |
| BMI, kg/m2 | 17.54±6.84 | 18.56±8.16 | 0.515 |
| Serum K, mmol/L | 4.43±0.60 | 4.21±0.77 | 0.725 |
| Serum Na, mmol/L | 138.49±3.86 | 137.59±5.55 | 0.130 |
| Serum Cl, mmol/L | 105.08±4.48 | 103.67±6.42 | 0.031 |
| Serum Ca, mmol/L | 2.32±0.13 | 2.29±0.20 | 0.020 |
| Serum P, mmol/L | 1.70±0.36 | 1.68±0.43 | 0.645 |
| Serum Mg, mmol/L | 0.86±0.10 | 0.90±0.15 | 0.003 |
Data are presented as mean±SD unless indicated. SD, standard deviation; BMI, body mass index; K, potassium; Na, sodium; Cl, chlorine; Ca, calcium; P, phosphate; Mg, magnesium
FigureThe sequencing map of APOE rs429358 and rs7412, the arrows indicate the mutation s namely, A: rs429358 TT; B: rs7412 CC; C: rs429358 TC; D: rs7412 CT; E: rs429358 CC; F: rs7412 TT.
Associations of rs429358 and rs7412 gene polymorphisms with children urolithiasis
| Patient group n (%) | Control group n (%) | OR (95%CI) | |
|---|---|---|---|
| rs429358a | |||
|
| 111 (81.6) | 218 (82.0) | 0.98 (0.57-1.67) |
|
| 25 (18.4) | 48 (18.0) | 1.00 |
|
| 247 (90.8) | 484 (91.0) | 0.98 (0.59-1.63) |
|
| 25 (9.2) | 48 (9.0) | 1.00 |
| rs7412b | |||
|
| 122 (89.7) | 232 (85.9) | 1.43 (0.75-2.74) |
|
| 14 (10.3) | 38 (14.1) | 1.00 |
|
| 258 (94.9) | 502 (93.0) | 1.40 (0.74-2.62) |
|
| 14 (5.1) | 38 (7.0) | 1.00 |
aIndividuals (n=5) with CC genotype in the control group were excluded from the analysis; bIndividual (n=1) with TT genotype in the control group was excluded from the analysis. OR, odds ratio; CI, confidence interval
Association of apolipoprotein E gene polymorphism with children urolithiasis
| Patient group (n=136) n (%) | Control group (n=259) n (%) | OR (95% CI) | |
|---|---|---|---|
| Genotype | |||
| 25 (18.4) | 42 (16.2) | 1.00 | |
|
| 97 (71.3) | 185 (71.4) | 0.88 (0.51-1.53) |
| 14 (10.3) | 32 (12.4) | 0.74 (0.33-1.64) | |
| Allele | |||
|
| 39 (3.6) | 86 (4.0) | 1.00 |
|
| 261 (24.0) | 522 (24.3) | 1.10 (0.73-1.66) |
|
| 505 (46.4) | 986 (46.0) | 1.13 (0.76-1.67) |
|
| 283 (26.0) | 550 (25.7) | 1.14 (0.76-1.70) |
aIndividuals (n=5, 6, 1) with the E4/4, E2/4 and E2/2 genotype in the control group were removed from our analysis, respectively. OR, odds ratio; CI, confidence interval